Kardas, R. C. And KÜÇÜK, H. 1. Comment on: Efficacy and safety of tocilizumab in Behcet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China. RHEUMATOLOGY , vol.62, no.4 .

Kardas, R. C., & KÜÇÜK, H., (1). Comment on: Efficacy and safety of tocilizumab in Behcet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China. RHEUMATOLOGY , vol.62, no.4.

Kardas, Riza, And HAMİT KÜÇÜK. "Comment on: Efficacy and safety of tocilizumab in Behcet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China," RHEUMATOLOGY , vol.62, no.4, 1

Kardas, Riza C. And KÜÇÜK, HAMİT. "Comment on: Efficacy and safety of tocilizumab in Behcet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China." RHEUMATOLOGY , vol.62, no.4, 1

Kardas, R. C. And KÜÇÜK, H. (1) . "Comment on: Efficacy and safety of tocilizumab in Behcet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China." RHEUMATOLOGY , vol.62, no.4.

@article{article, author={Riza Can Kardas And author={HAMİT KÜÇÜK}, title={Comment on: Efficacy and safety of tocilizumab in Behcet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China}, journal={RHEUMATOLOGY}, year=1}